Hyperglycemia is also known to be associated with hypoadiponectinemia [23], therefore additional decrease of adiponectin caused by NAFLD and hyperglycemia may aggravate subclinical atherosclerosis. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.